A detailed history of Hap Trading, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Hap Trading, LLC holds 142,600 shares of CYTK stock, worth $7.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
142,600
Previous 102,600 38.99%
Holding current value
$7.24 Million
Previous $201 Million 89.4%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$63.75 - $108.06 $25.2 Million - $42.7 Million
395,529 New
395,529 $27.7 Billion
Q3 2023

Nov 09, 2023

BUY
$29.46 - $36.61 $439,336 - $545,964
14,913 New
14,913 $439,000
Q1 2021

May 14, 2021

SELL
$18.57 - $25.68 $360,332 - $498,294
-19,404 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$15.26 - $28.61 $296,105 - $555,148
19,404 New
19,404 $403,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.78B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.